U.S. General Anesthesia Drugs Market Share to Witness Significant Revenue Growth
U.S. General Anesthesia Drugs Market Summary The U.S. general anesthesia drugs market size was valued at USD 1.72 billion in 2024 and is projected to grow at a CAGR of 2.82% from 2025 to 2030. This growth is supported by several factors, including the rising number of surgical procedures, continuous technological advancements in anesthesia administration, evolving regulatory frameworks, and significant shifts in healthcare practices. The American Society of Aesthetic Plastic Surgeons (ASPS) reported that 26.2 million surgical procedures were performed in the U.S. in 2022. Furthermore, data published by the National Library of Medicine highlighted that, in 2021, nearly nine major surgeries were conducted per 100 older adults, with more than one in seven Medicare beneficiaries undergoing a major surgery within five years. This reflects a substantial and increasing demand for reliable and effective general anesthesia drugs across the country. The growing number of surg...